Walleye Trading
RVNC

Walleye Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History

Walleye Trading’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,500
Closed -$140K – 5059
2024
Q1 		$140K Buy
28,500
+8,800
+45% +$52.1K ﹤0.01% 3622
2023
Q4 		$173K Buy
19,700
+19,200
+3,840% +$157K ﹤0.01% 3868
2023
Q3 		$5.74K Sell
500
-2,000
-80% -$38.5K ﹤0.01% 4614
2023
Q2 		$63.3K Buy
2,500
+2,200
+733% +$68.5K ﹤0.01% 3895
2023
Q1 		$9.66K Sell
300
-17,300
-98% -$539K ﹤0.01% 4374
2022
Q4 		$325K Buy
17,600
+16,600
+1,660% +$380K ﹤0.01% 3177
2022
Q3 		$27K Sell
1,000
-10,700
-91% -$217K ﹤0.01% 4375
2022
Q2 		$162K Buy
11,700
+8,900
+318% +$137K ﹤0.01% 3848
2022
Q1 		$55K Sell
2,800
-14,700
-84% -$223K ﹤0.01% 4482
2021
Q4 		$286K Buy
17,500
+15,000
+600% +$250K ﹤0.01% 3523
2021
Q3 		$70K Sell
2,500
-32,500
-93% -$927K ﹤0.01% 4524
2021
Q2 		$1.04M Buy
+35,000
New +$1.01M ﹤0.01% 2096
2021
Q1 		– Sell
-63,800
Closed -$1.81M – 5410
2020
Q4 		$1.81M Buy
63,800
+63,700
+63,700% +$1.65M 0.01% 1461
2020
Q3 		$3K Buy
+100
New +$2.62K ﹤0.01% 3996

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's RVNC Position: Q2 2024 in Review

Walleye Trading sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2024, closing a stake of 16,078 shares — an estimated $79.1K sold.

Walleye Trading first reported a position in RVNC in Q2 2015 and held it in 15 quarters. The position peaked at $2.85M in Q3 2022. 173 funds tracked by Wall St. Rank hold RVNC as of Q2 2024.

  • Walleye Trading reported no remaining Revance Therapeutics, Inc. position as of Q2 2024 after selling out during the quarter.
  • Walleye Trading sold 16,078 Revance Therapeutics, Inc. shares in Q2 2024, an estimated $79.1K.
  • Walleye Trading first reported a position in Revance Therapeutics, Inc. in Q2 2015 and held it in 15 quarters.
  • Walleye Trading's Revance Therapeutics, Inc. position peaked at $2.85M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2024.

Based on Walleye Trading's 13F filing for Q2 2024, filed 14 Aug 2024.